Northwell Health

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Northwell Health sits in the top decile of US sponsors by registered trial count (#95 of 15,742 sponsors by registered trial count).

370 total trials 81 currently recruiting 209 completed early-phase tilt top decile by trial count

Northwell Health: 370 sponsored US clinical trials, 81 recruiting.

Northwell Health sponsors 370 registered US clinical trials on ClinicalTrials.gov, 81 of them currently recruiting, and 209 completed. 38 of these trials are in Phase 3-4 (later-stage) and 80 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Schizophrenia, with 8 trials.

Top-decile sponsor footprint

Northwell Health ranks in the top decile of sponsors by registered trial count (#95 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 36/100

209 of 266 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (78.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

370 total, page 5 of 8

COMPLETED NA

Telehealth Pulmonary Rehabilitation for Hispanic and African-American Patients Admitted With Exacerbation of COPD

NCT03007485

COMPLETED NA

The Effect of Transcranial Direct Current Stimulation on Cognitive Side Effects of Electroconvulsive Therapy

NCT02897843

COMPLETED

Understanding Daily Fluctuations in Self-Regulation

NCT03006653

COMPLETED Phase 1

Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home

NCT02885311

COMPLETED NA

Kypho-Intra Operative Radiation Therapy (IORT) for Localized Spine Metastasis, Phase I/II Study

NCT02987153

COMPLETED NA

Using a Transcutaneous Electrical Auricular Stimulator to Harness the Cholinergic Anti-Inflammatory Pathway

NCT02910973

COMPLETED Phase 1

The Role of Trans-spinal Direct Current Stimulation (tsDCS) in Treating Patients With Hand Spasticity After Stroke

NCT03080454

COMPLETED NA

Music Therapy During Pediatric Extubation Readiness Trials

NCT02845947

COMPLETED NA

Transcutaneous Electric Nerve Stimulation (TENS) for the Treatment of Nocturnal Enuresis in Children

NCT02900495

TERMINATED NA

An Electronic Multimedia Discharge Application

NCT02752321

COMPLETED

Striatal Connectivity and Clinical Outcome in Psychosis

NCT02822092

TERMINATED Phase 1

Safety and Tolerability of MSI-1436C in Metastatic Breast Cancer

NCT02524951

COMPLETED NA

Comparing Force of Stream to Retrograde Fill Voiding Trial After Vaginal Apex Suspension

NCT02753920

COMPLETED

Ultrasonography in Hemophilic Joint Disease and Serum Markers

NCT02634918

COMPLETED

Prospective Evaluation of Residual Bile Duct Stone by Peroral Cholangioscopy After Conventional ERCP

NCT03482375

COMPLETED

Biomarkers of Spontaneous Recovery From Traumatic Spinal Cord Injury

NCT02731027

TERMINATED Phase 1

Super-selective Intra-arterial Cerebral Infusion of Trastuzumab for the Treatment of Cerebral Metastases of HER2/Neu Positive Breast Cancer

NCT02571530

TERMINATED Phase 1

Super-Selective Intraarterial Infusion of Cetuximab (Erbitux) With or Without Radiation Therapy for the Treatment of Unresectable Recurrent Squamous Cell Carcinoma of the Head and Neck

NCT02438995

COMPLETED NA

The Effect of Transcranial Direct Current Stimulation on Human Brains: A Neuroimaging Study

NCT02421146

COMPLETED NA

Adaptive Interventions for Problem Drinkers

NCT02511808

COMPLETED NA

Comparing Voiding Trials After Midurethral Sling for Stress Incontinence

NCT02400034

COMPLETED NA

The Use of Videoconferencing for Monitoring of Patients Post Urologic Surgery

NCT02771431

COMPLETED

Pleth Variability and Asthma Severity in Children

NCT02302261

COMPLETED Phase 2

Belimumab in Idiopathic Inflammatory Myositis

NCT02347891

COMPLETED Phase 3

Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies

NCT02566395

COMPLETED Phase 4

Liposomal Bupivacaine for Post Operative Pain After Knee Replacement Surgery

NCT02274870

COMPLETED NA

Effect of Total Compression Time and Rate (Slope) on Incidence of Symptomatic ETD and MEB: A Phase II Prospective Study.

NCT04776967

COMPLETED NA

Occult Paroxysmal Atrial Fibrillation in Non-Cryptogenic Ischemic Stroke

NCT02232022

COMPLETED Phase 3

Trial of Randomized Antibiotic Administration in Percutaneous Nephrolithotomy

NCT02579161

TERMINATED Phase 1

Evaluating Anodal tDCS Preceding Aphasia Therapy

NCT02249819

TERMINATED Phase 2

Nelfinavir in Systemic Lupus Erythematosus

NCT02066311

COMPLETED NA

The Effect of Visual Sternal Precautions on Behavioral Intentions and Readmissions

NCT02209558

COMPLETED NA

Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis

NCT02566057

TERMINATED Phase 4

Fluoxetine vs Aripiprazole Comparative Trial (FACT)

NCT02357849

COMPLETED NA

Tailored Mobile Text Messaging to Reduce Problem Drinking

NCT01885312

COMPLETED

Development of a Novel Glutamate Receptor Ligand for PET Scans in Neuropsychiatric Systemic Lupus Erythematosus

NCT02456168

COMPLETED NA

Telehealth Management in HF Disparity Patients

NCT02196922

COMPLETED Phase 2

Single Dose of Furosemide to Improve Respiratory Distress in Moderate to Severe Bronchiolitis

NCT02469597

COMPLETED NA

Healthy Transitions in Late Stage Kidney Disease

NCT02085837

TERMINATED NA

A Trial to Evaluate Negative Pressure Incision Management System for Groin Wounds in Vascular Surgery Patients

NCT02399111

TERMINATED Phase 2

Sodium Bicarbonate to Prevent Acute Kidney Injury in Children Undergoing Cardiac Surgery

NCT02046135

COMPLETED NA

Acute D2 Receptor Blockade Induced Neuronal Network Changes in Human Volunteers

NCT01931059

TERMINATED Phase 4

1/2-MC4R Genotype and Pediatric Antipsychotic Drug- Induced Weight Gain

NCT01844700

TERMINATED

Ileocecal Sphincter Reflex by Cecal Distension During Colonoscopy

NCT01413945

COMPLETED NA

The General Use of Robots in Stroke Recovery: the Anklebot

NCT02249832

COMPLETED Phase 1

Pilot Phase I/II Study of Amino Acid Leucine in Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia

NCT01362595

TERMINATED NA

Endoscopic Suturing of the Gastric Pylorus to Delay Gastric Emptying and Treat Obesity

NCT02191501

TERMINATED

In Vivo Anatomy, Physiology, Mechanics and Function of the Lower Esophageal Sphincter

NCT00737802

COMPLETED NA

Improving Care and Reducing Cost Study

NCT02364544

TERMINATED Phase 4

IV Acetaminophen for Postoperative Analgesia

NCT01798316

← Previous Page 5 of 8 Next →

Phase Distribution

PhaseTrial count
Phase 1 50
Phase 2 30
Phase 3 12
Phase 4 26

What is open in the Northwell Health pipeline

81 recruiting of 370 indexed (22% open); 209 completed (56%).

Phase mix: 38 late (III/IV) vs 80 early (I/II) (early-phase heavy).

Top condition: Schizophrenia (8 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Northwell Health: open-pipeline peers nationwide

Peers matched on 370 registered trials and 22% open enrollment, not the therapeutic-area sidebar.

Northwell Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300400500 0%5%10%15%20%25% Total trials Recruiting share Northwell HealthUniversity of California, IrvineUNC Lineberger Comprehensive Cancer CenterRoswell Park Cancer InstituteNew York State Psychiatric InstituteSt. Jude Children's Research HospitalRegeneron PharmaceuticalsAtriCureUniversity of Colorado, Boulder
Northwell Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Northwell Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 370 trials (± recruiting share)

Sponsors near 22% open enrollment (± trial volume)

What to do with this Northwell Health page

370 registered trials is a research-attention snapshot, not an endorsement of Northwell Health or any single study.

  • 81 of Northwell Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Schizophrenia is the condition Northwell Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Schizophrenia trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Northwell Health pipeline card: 370 registered trials from official public datasets.Report a data error.